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Enrico Clini, MD, FCCP
Study objective: To assess the clinical effectiveness of pulmonary rehabilitation (PR) after 10 or
20 consecutive sessions in outpatients with chronic airway obstruction (CAO).
Design: Observational prospective cohort trial.
Setting: Outpatient clinic of a rehabilitation center.
Patients and interventions: Twenty-five outpatients (mean age, 65  9 years [ SD]; FEV1,
64  12% predicted) admitted to a comprehensive PR program, including exercise training.
Measurements and results: The load reached on a cycloergometer (maximal achieved load
[W-max]), the maximal and isoload dyspnea and leg fatigue on a Borg scale, 6-min walk distance
(6MWD), and the health-related quality of life as assessed using the St. George’s Respiratory
Questionnaire (SGRQ) [total and components score] have been recorded as outcome measures at
baseline, after 10 sessions (T10), and after 20 sessions (T20). The predefined criteria of the
clinically significant improvement were as follows:  15%W-max,  54 m at 6MWD,  1 point at
isoload dyspnea and leg fatigue, and  4% at SGRQ scores. There was a mean significant
difference between changes at T20 and T10 for 6MWD ( 42.96 m; 95% confidence interval [CI],
 57.79 to  28.12 m; p  0.001), total SGRQ (4.80; 95% CI, 2.29 to 7.31; p  0.001), activity
SGRQ (3.60; 95% CI, 0.48 to 6.71; p  0.025), and symptoms SGRQ (5.96; 95% CI, 2.72 to 9.2;
p  0.001). The percentage of patients who improved was different at T20 as compared with T10
for W-max (68% and 48%, respectively; p  0.025), 6MWD (76% and 20%, p  0.001), and total
SGRQ (64% and 36%, p  0.008).
Conclusions: A 10-session course of PR provides only limited clinically significant changes of
outcome measures when compared with a 20-session course in outpatients with CAO of
mild-to-moderate severity. (CHEST 2005; 127:105–109)
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Abbreviations: CAO  chronic airway obstruction; CI confidence interval; GOLD Global Initiative for Obstruc-
tive Lung Disease; HRQoL health-related quality of life; MRCMedical Research Council; 6MWD 6-min walk
distance; PR pulmonary rehabilitation; SGRQ St. George’s Respiratory Questionnaire; T10 after 10 sessions;
T20  after 20 sessions; W-max maximal achieved load
P ulmonary rehabilitation (PR) has a well-estab-lished role in the management of patients with
chronic airway obstruction (CAO), particularly in
those with COPD.1 Several controlled studies2–4
have shown both short-term and long-term gains in
exercise capacity and health status of these patients.
Significant changes of outcome measures after PR
have been reported in patients with CAO of variable
severity5,6 and in different settings.7 Nonetheless, a
clinically significant improvement of these outcomes
have been reported in  50% of patients with
moderate-to-severe COPD admitted to a outpatient
program.8
However, the optimal length of PR in order to
obtain the best clinical efficacy has still to be deter-
mined in outpatients with CAO. The initial estimates
of the optimal length of outpatient PR were based on
the recommendations of the American College of
Sports Medicine for training in healthy individuals,
which suggests that a 6-week course is required to
achieve an aerobic training effect.9
Recently, it has been shown that PR (two sessions
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per week) provides greater benefit if delivered on a
7-week course than on a 4-week course basis in
COPD outpatients.10 In patients with COPD and
mild-to-moderate degree of severity, however, there
is still little to support 7 weeks (namely, 14 consec-
utive sessions) of training against any other reason-
able length of program. Therefore, we designed an
observational prospective study to compare the clin-
ical effectiveness of PR after 10 or 20 consecutive
sessions (three times per week) in outpatients with
mild-to-moderate CAO. All the study procedures
were conducted according to the declaration of
Helsinki
Materials and Methods
Patients
The studied patients were consecutively admitted to our
outpatient rehabilitation ambulatory unit. CAO was diagnosed,
and the cases were classified as mild-to-moderate degree CAO;
diagnosis of COPD was defined according to Global Initiative for
Obstructive Lung Disease (GOLD) staging and definition,1
whereas chronic asthma was characterized by variable airflow
limitation with reversible obstruction (range, 14 to 35%) and
bronchial hyperresponsiveness,11 in absence of smoking history.
All the included COPD patients had history of smoking ( 20
pack-years); four of them were current smokers.
Patients were referred directly from their general practitioner
due to the worsening of symptoms. In particular, all the admitted
patients complained of breathlessness (score  2 on the 5-point
Medical Research Council [MRC] scale).12 No change in the
treatment with inhaled bronchodilators and/or inhaled steroids (if
applied) was made in the 2 weeks preceding admission to our
hospital. Patients with any severe concomitant disease (ie, severe
left ventricular dysfunction, cancer), or inability or refusal to
cooperate were excluded from the study.
Study Protocol
The study was an observational prospective trial. Function
measures were obtained at admission (within 48 h). Outcome
measures were taken at baseline, after 10 sessions (T10), and
after 20 session (T20) of PR. All the measurements were
performed and recorded under the supervision of personnel not
aware of the study purpose. Comparisons have been made among
times, with each patient serving as his own control.
Measurements
Function Measures: Forced lung volumes were recorded by
means of a spirometer (Masterscope; Jaeger; Hochberg, Ger-
many). The predicted values according to Quanjer13 were used.
Arterial blood to obtain Pao2, Paco2, and pH by an automated
analyzer (model 850; Chiron Diagnostics; Medfield, MA) was
sampled at the radial artery, while patients in the sitting position
were breathing room air for at least 1 h. Respiratory muscle
strength was assessed by measuring maximal inspiratory pressure
and maximal expiratory pressure14 using a respiratory module
system (Masterscope PIMAX/PEMAX Module; Jaeger). The
reference values were those by Bruschi et al.15
Outcome Measures: Symptom-limited incremental exercise has
been performed on a electrically braked cycloergometer (Ergom-
etris 800-S; SensorMedics; Yorba Linda, CA) using the standard
10-W incremental symptom-limited cycle exercise protocol.16
Mixed-expired gas data and ECG activity were monitored continu-
ously, whereas systemic arterial BP was manually registered at each
minute interval. The maximal achieved load (W-max) was recorded
for analysis. At rest and at each interval, patients were asked their
perceived dyspnea and leg fatigue by pointing a number or phrase
on a 10-point modified Borg scale17 set in large type on a sheet in
front of them. The maximal (at baseline) and the isoload (at T10 and
T20) dyspnea and leg fatigue were recorded.
The timed walk distance in meters was assessed by the 6-min
walk test (6MWD) as recommended,18 while patients were
breathing room air. Health-related quality of life (HRQoL) has
been assessed by the Italian version of the St. George’s Respira-
tory Questionnaire (SGRQ)19: the total and each component
scores (activity, symptoms, impact) of the questionnaire were
measured.
Rehabilitation Program
The outpatient PR has been performed in patients admitted to
a five-bed day hospital facility. After initial evaluation by chest
physician and respiratory therapist, a multidisciplinary team
(consisting of nurse, physical therapist, dietician, and psycholo-
gist) also assessed the patient, thus formulating an individualized
rehabilitation plan. Patients performed 20 sessions (which were
held up to 3 h, three times per week) over consecutive weeks.
PR included instructions for compensatory breathing tech-
niques, energy conservation, stress management and symptoms
control, and optimization of the drug therapies. Each session
included the following: (1) supervised incremental exercise on a
cycloergometer; the training modality consisted of both progres-
sively increasing load (up to 70 to 80% of the maximal load
reached on the incremental test carried out at admission; a
dyspnea score  5 determined the ability of the single patient to
increase load); and time (up to 30 consecutive minutes starting
from a minimum of 10 minutes)20; (2) abdominal, and upper and
lower limb muscle strength activities, lifting weights (300 to
500 g),21 and circling shoulders and full arms22; (3) disease-
related education; and (4) nutritional and psychosocial counsel-
ing, when appropriate. Strategies to perform structured exercise
programs at home were not implemented. During all the study
period, patients were only encouraged to perform their usual
daily life activities.
Statistical Analysis
Data are shown as mean values with SD and/or 95% confi-
dence interval (CI), frequency, and/or percentage distribution.
Analysis was performed using a specific software package (SPSS
8.0 for Windows; SPSS; Chicago, IL); p 0.05 was considered
significant.
Outcomes were analyzed between times using analysis of
variance for repeated measures; a post hoc test was then applied,
if appropriate. The comparison of changes after 10 or 20 sessions
of PR was performed using an analysis of variance model
including the baseline value as the covariate; the between times
differences were expressed as the mean difference for all the
variables, with 95% CIs throughout.
The clinically significant improvement of the outcome mea-
sures was defined as follows:  15% W-max at the incremental
cycloergometry,23  54 m at the 6MWD,24  1 point at the Borg
scale,8 and  4% at each SGRQ score.25 The absolute and
percentage number of patients who improved (improvers) and
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who did not (nonimprovers) were reported at any time. Analysis
of difference between improvers and nonimprovers after 10 or 20
sessions was performed using the nonparametric Wilcoxon test.
Results
Table 1 shows the baseline characteristics of CAO
patients at hospital admission. Seven patients had
chronic asthma, whereas the remaining 18 COPD
patients were in GOLD stage I (mild COPD, 2 pa-
tients), GOLD stage II (moderate COPD, 11 patients),
and GOLD stage III (severe COPD, 5 patients).
HRQoL, as assessed by total SGRQ, showed a level of
clinically significant compromise ( 10 points) in all
the patients.
The included patients were attending their first
PR program, and all of them completed the 20
programmed sessions. Overall, exercise tolerance
(6MWD) and capacity (W-max), and SGRQ (total,
symptoms, and impact components) significantly im-
proved at T10 (p 0.01) and T20 (p 0.01) as
compared with baseline. Isoload dyspnea, but not
isoload leg fatigue, decreased at T20 (p 0.01)
[detailed data not shown].
The mean difference between changes obtained at
T20 and T10 was significant for 6MWD (p 0.001),
total SGRQ (p 0.001), activity SGRQ (p 0.025),
and symptoms SGRQ (p 0.001). Table 2 shows
this analysis in detail for all the considered variables.
The number and percentage of improvers or
nonimprovers after PR (see “Materials and Meth-
ods” for explanation) are shown in Table 3. The
percentage of improvers at T20 was higher than at
T10 when considering W-max (68% and 48%,
respectively; p 0.025), 6MWD (76% and 20%,
respectively; p 0.001), and total SGRQ (64% and
36%, respectively; p 0.008). Results were not in-
fluenced by diagnosis of either COPD or chronic
asthma (data not shown).
Discussion
This study has shown that a 20-session course of
PR including exercise training produces more signif-
icant improvements than a 10-session course in
outpatients with CAO of mild-to-moderate degree of
severity. Indeed, a 10-session course of PR provides
only a limited number of improvers among these
patients.
Overall, this study has confirmed that comprehen-
sive PR is able to improve exercise tolerance and
intensity as well as symptoms and HRQoL in pa-
tients with CAO treated as outpatients.6,26 Statisti-
cally significant changes have occurred after both 10
sessions (W-max, 6MWD, and SGRQ components)
and 20 sessions (W-max, 6MWD, isoload dyspnea,
and SGRQ components) of PR. Nonetheless, analy-
sis of changes between times has shown that sub-
stantial differences have arisen. Indeed, 6MWD and
SGRQ (total, activity, and symptoms scores) have
improved more after 20 sessions than after 10 ses-
sions (Table 2). This fact seems rather surprising,
given that the longer the program the higher are the
gains potentially obtained.4
The optimal length of a PR program delivered to
patients with CAO should not be shorter than 10 to
12 sessions.1 However, the optimal upper limit for
the length of PR in these patients has not been
established yet. Admission of patients with different
degrees of severity and local cost-effectiveness con-
Table 1—Baseline Demographic and Functional Data,
Exercise Assessment, and Health Status*
Variables Data
Male/female gender 17/8
COPD/asthma diagnosis 18/7
Age, yr 65 (9)
Body mass index 27 (3)
FEV1, % predicted† 64 (12)
FVC, % predicted† 92 (15)
Inspiratory capacity, % predicted† 96 (16)
FEV1/FVC, % 68 (5)
MIP, cm H2O 67 (17)
MEP, cm H2O 95 (23)
W-max, W 105 (29)
6MWD, m 448 (30)
Total SGRQ score 34 (14)
Activity SGRQ score 49 (14)
Symptoms SGRQ score 46 (18)
Impact SGRQ score 21 (16)
*Data are presented as No. or mean (SD). MEP maximal expira-
tory pressure; MIP  maximal inspiratory pressure.
†Postbronchodilator.
Table 2—Changes in Exercise Assessment, Symptoms,
and Health Status Following 10 or 20 Rehabilitation
Sessions: Data Comparisons Between T10 and T20 by
Analysis of Variance With Baseline Measurements
Taken as Covariates
Variables
Mean
Difference 95% CI p Value
W-max  4.20  8.76–0.36 0.070
6MWD  42.96  57.79– 28.12 0.001†
Dyspnea* 0.56  0.25–1.24 0.105
Leg fatigue* 0.40  0.47–0.55 0.873
Total SGRQ 4.80 2.29–7.31 0.001†
Activity SGRQ 3.60 0.48–6.71 0.025†
Symptoms SGRQ 5.96 2.72–9.20 0.001†
Impact SGRQ 2.08  0.89–5.04 0.161
*Maximal isoload values reached during cycloergometer testing.
†Level of significance for group differences.
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siderations might influence the total number of
allocated sessions. To the best of our knowledge,
there is only one study10 trying to compare the
efficacy of different lengths of PR (8 sessions vs 14
sessions). In this randomized parallel group trial10
carried out in 28 outpatients with moderate-to-
severe COPD, a 7-week course (14 sessions) of PR
provides greater benefit to patients (improvement of
HRQoL) than a 4-week course (8 sessions). Unfor-
tunately, they were not able to find any significant
advantage in terms of exercise capacity by comparing
the two groups.
Although the latter fact may arise from the rela-
tively small sample size, it is rather difficult to
compare results of our study with those obtained by
Green et al.10 Despite a similar delivered compre-
hensive PR program, we have treated different
patients, thus making any improvement rather com-
parable. A part of the treated patients in our study
was in the range of mild airway obstruction. The
question whether the level of bronchial obstruction
per se would be “the best” measure to assess the
patient’s severity and to include him/her in a PR
program still remains debatable. Other studies6,7
included CAO outpatients with a mean FEV1 similar
to that of our patients. Symptoms more than the
degree of airway obstruction should prompt physi-
cian to include patients into a rehabilitation program;
at admission, all our patients scored 2 on a 5-point
MRC scale.12
Notwithstanding, in the study by Green et al,10 the
authors suggested that it would have been interesting
to see whether results comparable to those achieved
after 14 sessions could have been reached including
a further 3-week period (6 sessions) of exercise
training in the shorter period group. This would have
determined whether the results obtained in that
study represented a “lag effect,” with improvements
in health status developing only after a longer period
of time. In this light, our study provides additional
information, in that HRQoL also changed signifi-
cantly after a shorter period of PR, at least in patients
with CAO of mild-to-moderate degree of severity.
Reaching the clinical threshold of improvement
appears the most appropriate way to see whether any
benefit can be obtained by the individual patient.8
The magnitude of change in different tools is impor-
tant because that magnitude may indicate the clinical
impact of the intervention. Therefore, a different
way to define benefits from PR is to assess which
proportion of patients has reached the clinical
threshold of improvement, as regard to the consid-
ered outcome variables.
De Torres et al8 has shown that symptoms (as
assessed by visual analog scale, baseline and transi-
tional dyspnea index, and MRC scale), and HRQoL
(as assessed by Chronic Respiratory Disease Ques-
tionnaire) changed to a clinically important threshold
after PR in  50% of outpatients with moderate-to-
severe COPD, while other parameters dealing with
exercise tolerance and intensity changed in  50%.
The authors8 suggested that measurements of symp-
toms and HRQoL are therefore more sensitive to
reflect the beneficial effect of PR.
In our study, we have found that parameters
measuring exercise capacity as well as those assessing
symptoms (at comparable workload) and HRQoL
(here as assessed by SGRQ) may significantly change
on a clinical basis in a consistent proportion of
patients with CAO both after 10 sessions and 20
sessions (Table 3). However, most importantly, the
percentage of patients showing such a clinically
relevant improvement was different (for 6MWD,
W-max, and total SGRQ) when comparing 10 ses-
sions with 20 sessions, thus suggesting that the
longer is the program the higher is the number (and
percentage) of patients who may really benefit from
PR, including supervised exercise.
As a matter of fact, the 20-session course, but not
the 10-session course, provided clinical benefits in
Table 3—Patients Showing Clinical Significant Improvement After 10 or 20 Rehabilitation Sessions*
Variables
T10 T20
p ValueImprover Nonimprover Improver Nonimprover
W-max 12 (48) 13 (52) 17 (68) 8 (32) 0.025†
6MWD 5 (20) 20 (80) 19 (76) 6 (24) 0.001†
Dyspnea‡ 11 (44) 14 (56) 17 (68) 8 (32) 0.134
Leg fatigue‡ 16 (64) 9 (36) 17 (68) 8 (32) 0.739
Total SGRQ 9 (36) 16 (64) 16 (64) 9 (36) 0.008†
Activity SGRQ 12 (48) 13 (52) 15 (60) 10 (40) 0.180
Symptoms SGRQ 16 (64) 9 (36) 18 (72) 7 (28) 0.414
Impact SGRQ 7 (28) 18 (72) 12 (48) 13 (52) 0.061
*Data are presented as No. (%).
†Level of significance for No. (%) distribution of patients between sessions.
‡Maximal isoload values reached during cycloergometer testing.
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 50% of patients. The percentage of improvers in
exercise capacity after 20 sessions in our study was
higher than that obtained by De Torres et al.8 The
different diagnosis and level of impairment in the
two studies might explain this result.
Our study has some limitations that need to be
carefully evaluated by readers. First, the protocol is not
delivered on a randomized parallel-group basis. How-
ever, when admitting outpatients with CAO to a stan-
dard PR program, we should refer all of them to a
standard length, as reported in the previously published
studies2,6,27 on similar subjects. Second, the sample size
is relatively small; nonetheless, the number of included
patients is not much different from that of previous
studies8,10,26,27 in this area. Additionally, all the subjects
completed evaluations without any missing data.
Therefore, we are confident that the obtained results
might be reproducible on a larger population of CAO
patients with similar characteristics.
In summary, outpatients with CAO of mild-to-
moderate severity admitted to a PR program includ-
ing training may largely benefit on a clinical basis if
they complete a 20-session program. Our study has
shown that a 20-session course (but not a 10-session
course) of comprehensive pulmonary rehabilitation
provides clinical effectiveness in  50% of patients,
thus suggesting that a shorter length for PR would be
of limited benefit. A variable cost-utility and cost-
benefit ratio might be therefore obtained depending
on the different length of the program; further
studies should be designed in order to address this
important implication.
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